Picture of Equillium logo

EQ — Equillium News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Equillium Inc reports results for the quarter ended in September - Earnings Summary

* Equillium Inc  EQ.OQ  reported a quarterly adjusted loss
of 40
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 38 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Equillium Inc's reported EPS for the quarter was a loss
of 40
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Equillium Inc shares had fallen by 23.3% this quarter and
lost 54.9% so far this year.
    * The company reported a quarterly loss of $13.66 million.
    * Wall Street's median 12-month price target for Equillium
Inc is
$12.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 09:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.38          -0.40          Missed
 Jun. 30 2022      -0.41          -0.41          Met
 Mar. 31 2022      -0.37          -0.45          Missed
 Dec. 31 2021      -0.34          -0.36          Missed

Recent news on Equillium

See all news